The study, led by Merel van der Straaten and Jeroen Dudink of the Wilhelmina Children’s Hospital at University Medical Center Utrecht and published in Pediatric Research, focused on the corpus callosum, the thick bundle of nerve fibers that connects the brain’s two hemispheres and enables them to communicate. The corpus callosum is not an arbitrary choice of measurement. Decades of research have shown that its size and growth rate in preterm infants track closely with later cognitive and motor outcomes, and that children born very preterm often show structural alterations in this region that persist into adolescence. Because the corpus callosum undergoes rapid development during exactly the period when preterm infants are in intensive care, its length serves as a sensitive, longitudinal biomarker of how the infant brain is maturing under hospital conditions.

What makes the new trial particularly striking is the elegance of the measurement strategy. Rather than relying on magnetic resonance imaging, which is difficult and risky to perform repeatedly in fragile newborns, the researchers used cranial ultrasound, a bedside tool already routinely deployed in neonatal units. On a mid-sagittal ultrasound image, the corpus callosum appears as a clearly delineated crescent, allowing its length to be measured quickly and safely at multiple time points during the hospital stay. This approach transforms brain development from something assessed once, late in the hospitalization, into a growth curve that can be tracked in real time, giving researchers and clinicians a dynamic picture of how interventions influence the maturing brain.

Seventy-six preterm infants took part in the single-blind randomized controlled trial, conducted within the neonatal intensive care unit in Utrecht. Forty-two infants were assigned to the music intervention group and thirty-four to a placebo group. The intervention itself was deliberately minimal: an eight-minute daily exposure to Brahms’ Lullaby, delivered for up to fifteen sessions. The researchers chose a single, standardized piece of music to ensure that any observed effect could be attributed to the intervention as a whole rather than to variations in musical content. The placebo design is important, because it distinguishes the physiological effect of structured auditory stimulation from the mere presence of extra attention or handling, which can itself influence infant behavior and physiology.

The results were unambiguous. Infants who received the music intervention showed a significantly steeper daily increase in corpus callosum length compared with those in the placebo group, a difference that reached the stringent threshold of p less than 0.001. Crucially, the effect persisted after the researchers adjusted for several covariates in a linear mixed model, the statistical framework of choice for longitudinal growth data because it can accommodate repeated measurements taken at irregular intervals across individuals. In plain terms, the babies who heard music every day were building the bridge between their brain hemispheres faster than comparable babies who did not, and the difference was not explained by factors such as illness severity or baseline characteristics.

The trial builds on a rich but previously indirect literature. Earlier observational work from Geneva, using diffusion magnetic resonance imaging, found that very preterm infants exposed to live music in the neonatal unit showed enhanced structural maturation of neural pathways involved in emotional processing, and a separate study from the same group reported that music exposure was associated with strengthened high-level cognitive brain networks. Researchers at Harvard had previously demonstrated that recorded maternal voice and heartbeat sounds could elicit auditory cortical plasticity before full gestation. Clinical trials of music therapy have reported improvements in vital signs, feeding, sleep, and comfort scores in preterm infants. What most of these studies lacked, however, was a direct, structural, brain-based outcome measured longitudinally in a randomized design. The Utrecht trial supplies exactly that, linking a low-burden auditory intervention to accelerated growth of a well-characterized neuroanatomical structure.

The biological plausibility of the finding rests on the principle of experience-dependent plasticity. The auditory system is functional well before birth, and the fetal brain normally develops in a rich acoustic environment dominated by maternal voice, heartbeat, and filtered external sounds. Preterm birth abruptly removes this stimulation, and animal and human studies have shown that chronic stress and sensory deprivation during critical developmental windows can impair structural brain growth, including in white matter tracts. A predictable, gentle, structured auditory stimulus such as a lullaby may partially restore the pattern of stimulation the developing brain expects, promoting the activity-dependent processes, from axonal growth to myelination, that drive corpus callosum elongation. The corpus callosum is particularly interesting in this regard because its development is protracted and experience-sensitive, making it a plausible target for environmental enrichment.

From a practical standpoint, the intervention’s simplicity may be its most important feature. Eight minutes of recorded music requires no specialized equipment, no trained music therapist on site at all times, and no disruption to standard care routines. This stands in contrast to live music therapy interventions, which have shown promise but depend on the availability of certified professionals and are harder to standardize or scale. The Utrecht team notes that the intervention was feasible within routine neonatal intensive care, and their earlier randomized trial in the same population had already demonstrated that the same daily music protocol improved comfort scores in preterm infants, suggesting a consistent picture of benefit across behavioral and now structural outcomes. If the findings replicate, a lullaby could become one of the cheapest neuroprotective interventions available in neonatology.

The researchers and independent commentators alike are careful about what the study does and does not show. The outcome was a structural biomarker, not long-term neurodevelopmental performance, and the authors explicitly call for future research to elucidate the mechanisms underlying the effect, optimize the intervention protocol, and evaluate long-term cognitive, motor, and emotional outcomes. Questions remain about whether the effect depends on the specific musical properties of Brahms’ Lullaby, such as its slow tempo and predictable phrase structure, or whether any gentle, structured auditory stimulus would work. The optimal dose, timing, and duration of exposure are unknown, and some voices in the field have cautioned against assuming that any music, played at any volume, is inherently beneficial for preterm infants, emphasizing that poorly designed auditory environments can add to neonatal stress rather than relieve it.

Nevertheless, the trial marks a meaningful shift in how the field can evaluate sensory interventions in the neonatal unit. By pairing a simple, scalable intervention with a bedside measure of brain growth, the study demonstrates that the developing preterm brain responds to its auditory environment in ways that can be detected within weeks, not years. It also reframes the neonatal intensive care unit not merely as a place where premature infants are kept alive while their brains mature passively, but as an environment whose sensory design can actively shape that maturation. For the roughly one in ten infants born preterm worldwide, and for the parents who sit beside their incubators, the idea that a familiar lullaby might be helping to wire their baby’s brain, one eight-minute session at a time, is a finding that resonates far beyond the statistics.

Subject of Research: The effect of daily recorded music exposure on corpus callosum growth in preterm infants

Article Title: Recorded music exposure and brain growth in preterm infants: a randomized controlled trial

Article References: van der Straaten, M., Snethlage, A. T. W., Volk, A., Zuithoff, N. P. A., van den Hoogen, A., Benders, M., Tataranno, M.-L., & Dudink, J. (2026). Recorded music exposure and brain growth in preterm infants: a randomized controlled trial. Pediatric Research. https://doi.org/10.1038/s41390-026-05393-7

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05393-7

Keywords: preterm infants, music intervention, corpus callosum, brain development, neonatal intensive care, randomized controlled trial, cranial ultrasound, auditory stimulation, neurodevelopment, Brahms' Lullaby, experience-dependent plasticity, Pediatric Research

That apparent normality did not last. During his four-week admission he suffered several further episodes of transient hypothermia accompanied by hypertension and sweating, each resolving spontaneously. Over the following four years he was admitted more than a dozen times with the same constellation of symptoms: hypothermia plunging as low as 28 degrees Celsius, profuse diaphoresis, blood pressure disturbance that swung between severe hypertension and profound hypotension, and symptomatic hyponatremia with sodium levels between 119 and 132 mmol/L. On every occasion, repeat testing found no evidence of infection or endocrine disease. This pattern of periodic hypothermia, autonomic instability and low sodium pushed the clinical team toward an entirely different explanation: a thermoregulatory disorder originating in the central nervous system. When the authors re-examined his prior brain imaging, they found something the original report had missed, an abnormality of the corpus callosum together with a cavum veli interpositi, a fluid-filled structure that can accompany callosal malformations.

Those findings were supportive of a diagnosis of Shapiro syndrome, an extraordinarily rare condition first described in 1969 by Shapiro, Williams and Plum in two patients who presented with spontaneous episodic hypothermia and hyperhidrosis alongside radiographic evidence of agenesis of the corpus callosum. The corpus callosum is the thick bundle of nerve fibres connecting the brain’s two hemispheres, and its absence or malformation is the structural hallmark of the syndrome. Since the original description, the recognised phenotype has expanded to include other autonomic disturbances such as hypertension or hypotension, altered consciousness and metabolic derangement. Of the approximately 60 cases reported in the literature, about half had no evidence of callosal dysgenesis at all; these are considered a variant of the syndrome, sometimes called episodic spontaneous hypothermia, and they tend to affect older patients.

Understanding why such a syndrome can exist requires understanding how tightly the human body normally controls its temperature. The evolution of mammals from aquatic to terrestrial life posed a serious thermoregulatory challenge, because land temperatures vary far more than water temperatures. That pressure drove a transition from poikilothermy, in which body temperature drifts with the environment, to homeothermy, the ability to hold internal temperature within a narrow set range. Holding a high, stable temperature maximises enzymatic activity, speeds neural processing and improves healing. Endothermy, the generation of internal heat, gave early mammals a survival edge over ectothermic dinosaurs, which depended on external heat sources, were inactive at night, were more vulnerable to seasonal change and were in some cases restricted to particular latitudes.

In humans, the hypothalamus acts as the thermostat. The pre-optic area of the anterior hypothalamus is chiefly responsible for temperature control, integrating thermal signals arriving from skin and visceral thermoreceptors with direct measurements of hypothalamic temperature. Within this region, distinct populations of neurons perform complementary roles. Warm-sensing neurons increase their activity in response to heat and receive excitatory input from peripheral warm receptors; when they fire, they trigger heat-loss mechanisms such as sweating and peripheral vasodilation. Cold-sensing neurons make up less than 5 percent of the pre-optic population and are normally held in check by tonic inhibition from warm-sensing neurons, balanced against tonic excitation from temperature-insensitive neurons. When that inhibition is lifted, cold-defence mechanisms activate: shivering and non-shivering thermogenesis, peripheral vasoconstriction, activation of brown fat through sympathetic excitation, hypothalamic-pituitary stimulation of thyroxine production to raise basal metabolic rate, and even behavioural responses like huddling. Infection complicates this picture because endogenous pyrogens suppress warm-sensing neurons, raising the set point and producing fever.

Hypothermia itself is defined as a core temperature below 35 degrees Celsius and is graded as mild, between 32 and 35 degrees, moderate, between 28 and 32 degrees, or severe, below 28 degrees. The physiological consequences scale with severity. At the cellular level, cold drives water crystallisation, membrane disruption and protein changes, while secondary ischaemic injury follows vasoconstriction, endothelial damage and thrombosis. Mild hypothermia typically produces a catecholamine surge with tachycardia and hypertension, which may explain the striking blood pressure of 207/176 mmHg in the case described here. As temperature falls further, cardiovascular function degrades into progressive bradycardia and hypotension. Cerebral metabolic rate drops by roughly 6 percent for every 1-degree Celsius decline, producing confusion, behavioural change, ataxia and progressive obtundation. Respiratory drive is depressed, causing respiratory acidosis, while cold diuresis, impaired renal tubular function and occasional shivering-induced rhabdomyolysis disturb electrolytes, a mechanism relevant to the patient’s recurrent hyponatremia. Coagulopathy from platelet and clotting-factor dysfunction is also common.

Because so many conditions can lower body temperature, clinicians must work through a broad differential. Exogenous hypothermia from environmental exposure is compounded by age, intoxication, homelessness, low body fat and immobility. Endogenous causes include sepsis, especially gram-negative bacteraemia, hypovolaemic shock, hypoglycaemia, diabetic ketoacidosis, uremia and hepatic encephalopathy, and endocrinopathies such as hypothyroidism, adrenal failure and hypopituitarism. Drugs matter too: alcohol, opioids, barbiturates and phenothiazines impair thermal perception and cause vasodilation, while at the opposite extreme, neuroleptic malignant syndrome, serotonin syndrome and malignant hyperthermia produce dangerous overheating. Neurological causes form their own category. Peripheral neuropathies rarely cause overt thermoregulatory failure except in rare genetic disorders such as congenital insensitivity to pain with anhidrosis. Spinal cord injuries, particularly high cervical lesions, impair both afferent temperature sensing and efferent responses like shivering and vasomotor control. Focal lesions of the hypothalamus or brainstem, demyelinating disease, autoimmune encephalitis and neurodegenerative conditions such as Parkinson’s disease can all disrupt central temperature control, and episodic hypothermia has been documented in migraine, HIV, Parkinson disease and multiple sclerosis.

The authors argue that a central thermoregulatory disorder should be suspected whenever a patient presents with unexplained hypothermia or hyperthermia, particularly without environmental triggers, infection, endocrinopathy or organ failure. It remains largely a diagnosis of exclusion. Additional neurological signs such as autonomic dysfunction or altered mental status may point toward a central cause, though they can also result directly from the thermal derangement itself. Structural brain imaging is paramount in such cases, precisely because the decisive clue in this patient, callosal dysgenesis with a cavum veli interpositi, was present on an earlier scan but initially overlooked. The case is a striking reminder that radiological findings can hide in plain sight until the clinical pattern demands a second look.

Why the corpus callosum matters in Shapiro syndrome is still unresolved, and dysgenesis alone is clearly insufficient to cause the disorder. Hypothalamic involvement is supported by findings of hypothalamic neuronal loss in some reported cases, although structural imaging is often normal. Shapiro’s original hypothesis of diencephalic epilepsy has not held up: patients rarely show EEG abnormalities and generally do not respond to anticonvulsants. Alternative mechanisms, including neurotransmitter dysfunction and hypermelatoninemia, have been proposed, but the cause-and-effect relationship is difficult to disentangle. Some support for the neurotransmitter hypothesis comes from occasional responses to prophylactic agents such as clonidine, clomipramine and cyproheptadine. The patient in this report briefly received clonidine, but treatment was not continued because of poor response, non-compliance and episodes of hypotension, underscoring how difficult management can be in a condition whose mechanisms remain obscure.

The broader lesson from this case extends beyond one rare syndrome. Virtually any neurological disease affecting cognition, sensation or movement can increase susceptibility to thermal dysregulation, but periodic hypothermia and hyperthermia should prompt consideration of a central disorder once infection and systemic disease have been excluded. Diagnostic precision matters because treatment strategies, both pharmacological and non-pharmacological, differ according to the underlying cause, and misattributing recurrent hypothermia to infection leads to repeated courses of unnecessary antimicrobials, as happened here before the true diagnosis emerged. For a man whose body temperature repeatedly fell to levels that would kill most people within hours, the answer lay not in his blood but in a structure of his brain that no one had looked at carefully enough, until a decade of mysterious admissions finally forced a second reading of the scan.

Subject of Research: Shapiro syndrome, a rare disorder of central thermoregulation associated with agenesis of the corpus callosum

Article Title: Recurrent Hypothermia and Autonomic Dysfunction Secondary to Shapiro Syndrome

Article References: Kumar, N., Johnson, J., Watkins, S., & Mulroy, E. (2026). Recurrent Hypothermia and Autonomic Dysfunction Secondary to Shapiro Syndrome. Annals of Clinical and Translational Neurology, 13(8), 1719-1725. https://doi.org/10.1002/acn3.70419

Image Credits: AI Generated

DOI: 10.1002/acn3.70419

Keywords: Shapiro syndrome, hypothermia, corpus callosum, hypothalamus, thermoregulation, autonomic dysfunction, hyperhidrosis, hyponatremia, neurology, case report, episodic spontaneous hypothermia, diencephalon

The experimental design was deliberately comprehensive. Eighty-four adult male Wistar rats, each weighing between 100 and 120 grams, were randomly assigned to six groups. One group served as a control and received only deionized water, while the remaining five groups received sodium fluoride dissolved in deionized water at concentrations of 25, 50, 100, 150, and 300 parts per million, equivalent to 25 to 300 milligrams per liter. These doses deliberately exceed the World Health Organization guideline value of 1.5 milligrams per liter for fluoride in drinking water, but they fall within or above concentrations actually reported in groundwater from regions where fluorosis is endemic, making the findings directly relevant to millions of people worldwide who rely on fluoride-contaminated water sources. Seven rats from each group were evaluated at the 30-day mark and seven at 60 days, allowing the researchers to distinguish short-term from longer-term effects.

Behavioral testing using the open field assay revealed striking disturbances in both locomotion and anxiety-like behavior. In the 30-day exposure groups, rats receiving 25 milligrams per liter traveled significantly shorter distances and moved more slowly than controls, while animals at 50, 150, and 300 milligrams per liter showed significant reductions in maximum speed. Perhaps most tellingly, the treated rats exhibited disrupted movement patterns: increased angular velocity and meandering, reduced ability to maintain a straight path, and elevated anticlockwise rotation. Rats at the highest dose of 300 milligrams per liter showed markedly reduced freezing latency, suggesting an anxiety profile fundamentally different from controls. At 60 days, the pattern shifted, with some doses increasing distance traveled while others decreased mobility time, altered freezing behavior, and disrupted path efficiency, indicating that the behavioral consequences of fluoride exposure evolve over time rather than simply worsening in a linear fashion.

Beneath these behavioral changes, the biochemical assays painted a picture of severe oxidative stress in two critical brain regions, the hippocampus and the striatum. Malondialdehyde, a marker of lipid peroxidation and cellular membrane damage, rose in a dose-dependent fashion after 30 days of exposure. Hydrogen peroxide levels climbed while the brain’s antioxidant arsenal collapsed: reduced glutathione, superoxide dismutase, and glutathione peroxidase all declined significantly across treated groups. The brain is especially vulnerable to this kind of oxidative assault because it consumes enormous quantities of oxygen and is packed with polyunsaturated fatty acids that are prime targets for free radical attack. The researchers note that fluoride appears to suppress antioxidant defenses both directly, through competitive inhibition of protective enzymes, and indirectly, by generating a flood of reactive oxygen species that overwhelms them.

One of the most consistent findings across every dose and every time point was a significant reduction in acetylcholinesterase activity in both the hippocampus and the striatum. Acetylcholinesterase is the enzyme responsible for breaking down acetylcholine, a neurotransmitter central to learning, memory, attention, and motor control. Its inhibition means acetylcholine lingers longer at synapses, disrupting normal cholinergic transmission. This mechanism is pharmacologically significant because acetylcholinesterase inhibition is also the mode of action of certain nerve agents and pesticides, and reduced cholinergic transmission is implicated in cognitive decline. The authors suggest that the disrupted motor function and altered emotional states observed in the open field tests may be directly linked to this cholinergic impairment, providing a mechanistic bridge between molecular chemistry and observable behavior.

The immunohistochemical analysis added structural evidence to the biochemical story. In the striatum, the researchers documented elevated immunoreactivity for glial fibrillary acidic protein, or GFAP, a hallmark marker of astrocyte activation. Astrocytes normally support neurons by secreting neurotrophic factors, but when they proliferate excessively in response to injury, a process called astrogliosis, they can obstruct neurite outgrowth and impede tissue regeneration. After 60 days of exposure, the increase in astrocyte population was particularly pronounced. Gliosis is the brain’s intrinsic response to damage, and its presence here confirms that sodium fluoride exposure registers in the brain as genuine injury rather than a transient, reversible perturbation.

Equally concerning was the fate of the myelin sheath, the fatty insulation that wraps nerve fibers and enables rapid, efficient signal transmission. Rats exposed to sodium fluoride for both 30 and 60 days showed significantly reduced immunoreactivity for myelin basic protein in the corpus callosum, the massive fiber bundle connecting the brain’s two hemispheres. Demyelination is a serious form of neurological damage, characteristic of diseases such as multiple sclerosis, and its occurrence following chemical toxicity is well documented. The loss of myelin basic protein indicates breakdown of the intact myelin sheath, which would slow or scramble communication between brain regions and could plausibly underlie the motor coordination deficits and abnormal movement patterns recorded in the behavioral tests. Previous research has shown that fluoride can induce degenerative changes across the brain and spinal cord, including axonal degradation, mitochondrial impairment, and synaptic ultrastructural changes, and this study adds region-specific myelin loss to that inventory of harm.

Integrating these findings, the authors propose a coherent mechanistic chain: sodium fluoride exposure generates reactive oxygen species, depletes antioxidant defenses, and drives lipid peroxidation; this oxidative environment damages cholinergic neurons and triggers astrocytic proliferation; the resulting neuroinflammation and myelin degradation cumulatively degrade motor function, coordination, and anxiety regulation. The study’s strength lies in this multi-level convergence, linking behavioral observation with biochemical assay and structural histology in the same animals, something many earlier single-endpoint studies could not do. The connection to human health is not lost on the researchers, who note that epidemiological studies in regions with fluoride levels far exceeding WHO standards have reported significantly lower IQ scores in children, and that both juvenile and adult subjects exposed to elevated fluoride show diminished learning capacity and memory deficits.

The authors are careful to acknowledge the limitations of their work. All experiments were conducted in male rats, and since sex-specific differences in toxin susceptibility are widely reported, the findings may not fully generalize to females. Future studies incorporating female animals will be needed to determine whether these effects are sex dependent. The doses used, while environmentally relevant to fluorosis-endemic regions, sit well above typical fluoridated municipal water levels, so the results should not be read as an indictment of water fluoridation at recommended concentrations. Nevertheless, for the substantial populations in countries including Nigeria, India, Kenya, and China who drink groundwater with fluoride concentrations matching or exceeding those tested here, the implications are sobering. The study demonstrates that fluoride at these levels compromises brain health through oxidative stress, astrocytosis, and disrupted myelination, ultimately producing measurable neurobehavioral impairment, and it provides a detailed mechanistic framework that future protective interventions, whether antioxidant, cholinergic, or anti-inflammatory, can now be tested against.

Subject of Research: Neurotoxic effects of 30- and 60-day sodium fluoride exposure on behavior, brain chemistry, and myelin integrity in adult Wistar rats

Article Title: 30- and 60-days exposure of sodium fluoride induces neurobehavioral deficits and alters neurochemical parameters in adult Wistar rats

Article References: 30- and 60-days exposure of sodium fluoride induces neurobehavioral deficits and alters neurochemical parameters in adult Wistar rats. (n.d.). https://doi.org/10.1007/s44339-026-00051-3

Image Credits: AI Generated

DOI: 10.1007/s44339-026-00051-3

Keywords: sodium fluoride, neurotoxicity, oxidative stress, Wistar rats, acetylcholinesterase, myelin basic protein, GFAP, hippocampus, striatum, corpus callosum, neurobehavioral deficits, fluoridation